CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this interventional study is to evaluate if the novel diagnostic blood test, called Avantect can early detect pancreatic cancer...
London, United Kingdom and 13 other locations
This is an open-label, multi-centre, randomised, stratified, phase IIb clinical trial of ATRA administered in combination with gemcitabine and nab-pa...
Phase 2
London, United Kingdom
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
London, United Kingdom and 76 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
London, City Of London, United Kingdom and 91 other locations
is to assess the safety and efficacy of OncoSil™ when given in addition to standard FOLFIRINOX chemotherapy for treatment of Locally Advanced Pancreatic...
Phase 2
London, United Kingdom and 16 other locations
This is a study designed to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of WEF-001 as monotherapy in patients with Adv...
Phase 1, Phase 2
Headington, Oxford, United Kingdom and 2 other locations
This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....
Phase 1, Phase 2
Sutton, United Kingdom and 67 other locations
to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...
Phase 2
London, United Kingdom and 63 other locations
This is a multi-centre, investigator-initiated, dose escalation, Phase I trial of the combination of the FAK inhibitor, Defactinib (VS-6063), and the...
Phase 1
London, United Kingdom and 4 other locations
efficacy of AZD9574 individually and in combination with anti-cancer agents in participants with advanced cancer that has recurred/...
Phase 1, Phase 2
London, United Kingdom and 32 other locations
Clinical trials
Research sites
Resources
Legal